Thalomid thalidomide: Phase II; marketed to treat cutaneous manifestations of erythema nodosum leprosum (ENL)

In an open label trial of 63 patients with androgen-independent prostate cancer, 200

Read the full 136 word article

How to gain access

Continue reading with a
two-week free trial.